Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Depreciation and Depletion (2022 - 2025)

Historic Depreciation and Depletion for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $6840.0.

  • Coya Therapeutics' Depreciation and Depletion fell 1.46% to $6840.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27360.0, marking a year-over-year change of 0.37%. This contributed to the annual value of $27361.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Coya Therapeutics' Depreciation and Depletion stood at $6840.0, which was down 1.46% from $6840.0 recorded in Q2 2025.
  • Coya Therapeutics' Depreciation and Depletion's 5-year high stood at $12455.0 during Q3 2022, with a 5-year trough of $4033.0 in Q1 2022.
  • Moreover, its 4-year median value for Depreciation and Depletion was $6840.0 (2022), whereas its average is $6840.2.
  • Data for Coya Therapeutics' Depreciation and Depletion shows a peak YoY increase of 6960.08% (in 2023) and a maximum YoY decrease of 4507.43% (in 2023) over the last 5 years.
  • Over the past 4 years, Coya Therapeutics' Depreciation and Depletion (Quarter) stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then changed by 0.0% to $6840.0 in 2025.
  • Its Depreciation and Depletion was $6840.0 in Q3 2025, compared to $6840.0 in Q2 2025 and $6840.0 in Q1 2025.